Data as of Sep 15
 -0.16 / -1.99%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

POZEN, Inc. manufactures and markets pharmaceutical products. It is pharmaceutical company that specializes in developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. The company's Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. PA Product Portfolio consists of PA8140 and PA32540. Its licensed products include Treximet, MT 400 and VIMOVO. POZEN was founded by John R. Plachetka on September 25, 1996 and is headquartered in Chapel Hill, NC.

Contact Information

1414 Raleigh Road
Chapel Hill North Carolina 27517
P:(919) 913-1030
Investor Relations:
(919) 913-1074



Other institutional43.24%
Individual stakeholders25.14%
Mutual fund holders13.30%

Top Executives

John R. PlachetkaChairman, President & Chief Executive Officer
William L. HodgesChief Financial Officer & Senior VP-Administration
John G. FortChief Medical Officer
John E. BarnhardtVice President-Finance & Administration
Dennis L. McNamaraChief Business Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.